https://doi.org/10.1016/j.semcancer.2019.08.019
C
Crescenzo D’Alterio
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
105
Papers
1.8K
Citations
23
h-index
38
i10-index
Crescenzo D’Alterio is an academic researcher. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Chemokine receptors and signaling & Renal cell carcinoma treatment. The author has an h-index of 23, co-authored 90 publications.
ORCID: 0000-0003-0275-3367Papers by this author
worksParadoxical effects of chemotherapy on tumor relapse and metastasis promotion
2019 · Seminars in Cancer Biology · 208 citations
Targeting CXCR4 potentiates anti-PD-1 efficacy modifying the tumor microenvironment and inhibiting neoplastic PD-1
2019 · Journal of Experimental & Clinical Cancer Research · 105 citations
https://doi.org/10.1186/s13046-019-1420-8
Melanoma and immunotherapy bridge 2015
2016 · Journal of Translational Medicine · 24 citations
https://doi.org/10.1186/s12967-016-0791-2
Mutated Von Hippel-Lindau-renal cell carcinoma (RCC) promotes patients specific natural killer (NK) cytotoxicity
2018 · Journal of Experimental & Clinical Cancer Research · 20 citations
https://doi.org/10.1186/s13046-018-0952-7
A novel CXCR4-targeted near-infrared (NIR) fluorescent probe (Peptide R-NIR750) specifically detects CXCR4 expressing tumors
2017 · Scientific Reports · 19 citations
https://doi.org/10.1038/s41598-017-02818-6
A novel CXCR4 antagonist counteracts paradoxical generation of cisplatin-induced pro-metastatic niches in lung cancer
2021 · Molecular Therapy · 18 citations
https://doi.org/10.1016/j.ymthe.2021.05.014
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat